Literature DB >> 20652837

Distinct gene expression profiles directed by the isoforms of the transcription factor neuron-restrictive silencer factor in human SK-N-AS neuroblastoma cells.

Stuart G Gillies1, Kate Haddley, Sylvia A Vasiliou, Gregory M Jacobson, Bengt von Mentzer, Vivien J Bubb, John P Quinn.   

Abstract

Neuron-restrictive silencer factor (NRSF) and its isoforms are differentially regulated in rodent models of self-sustaining status epilepticus (SSSE). NRSF isoforms regulate genes associated with SSSE, including the proconvulsant tachykinins, brain-derived neurotrophic factor and multiple ion channels. NRSF isoforms may direct distinct gene expression patterns during SSSE, and the ratio of each isoform may be a causative factor in traumatic damage to the central nervous system. Here, we analysed global gene expression changes by microarray in human SK-N-AS neuroblastoma cells following the over-expression of NRSF and a truncated isoform, HZ4. We used bioinformatics software to analyse the microarray dataset and correlated these data with epilepsy candidate gene pathways. Findings were validated by reverse transcriptase-polymerase chain reaction. We demonstrated that NRSF and HZ4 direct overlapping as well as distinct gene expression patterns, and that they differentially modulated gene expression patterns associated with epilepsy. Finally, we revealed that NRSF gene expression may be modulated by the anticonvulsant, phenytoin. We have interpreted our data to reflect altered gene expression directed by NRSF that might be relevant for SSSE.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20652837     DOI: 10.1007/s12031-010-9420-3

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  72 in total

1.  Differential actions of nerve growth factor receptors TrkA and p75NTR in a rat model of epileptogenesis.

Authors:  Songlin Li; H Uri Saragovi; Hinko Nedev; Chunnian Zhao; Ronald J Racine; Margaret Fahnestock
Journal:  Mol Cell Neurosci       Date:  2005-06       Impact factor: 4.314

Review 2.  Endogenous channels in HEK cells and potential roles in HCN ionic current measurements.

Authors:  Anthony Varghese; Erica M Tenbroek; James Coles; Daniel C Sigg
Journal:  Prog Biophys Mol Biol       Date:  2005-06-08       Impact factor: 3.667

3.  Synergy between the RE-1 silencer of transcription and NFkappaB in the repression of the neurotransmitter gene TAC1 in human mesenchymal stem cells.

Authors:  Steven J Greco; Sergey V Smirnov; Raghav G Murthy; Pranela Rameshwar
Journal:  J Biol Chem       Date:  2007-08-20       Impact factor: 5.157

4.  Mutations in LGI1 cause autosomal-dominant partial epilepsy with auditory features.

Authors:  Sergey Kalachikov; Oleg Evgrafov; Barbara Ross; Melodie Winawer; Christie Barker-Cummings; Filippo Martinelli Boneschi; Chang Choi; Pavel Morozov; Kamna Das; Elita Teplitskaya; Andrew Yu; Eftihia Cayanis; Graciela Penchaszadeh; Andreas H Kottmann; Timothy A Pedley; W Allen Hauser; Ruth Ottman; T Conrad Gilliam
Journal:  Nat Genet       Date:  2002-01-28       Impact factor: 38.330

5.  REST maintains self-renewal and pluripotency of embryonic stem cells.

Authors:  Sanjay K Singh; Mohamedi N Kagalwala; Jan Parker-Thornburg; Henry Adams; Sadhan Majumder
Journal:  Nature       Date:  2008-03-23       Impact factor: 49.962

6.  Multicentre search for genetic susceptibility loci in sporadic epilepsy syndrome and seizure types: a case-control study.

Authors:  Gianpiero L Cavalleri; Michael E Weale; Kevin V Shianna; Rinki Singh; John M Lynch; Bronwyn Grinton; Cassandra Szoeke; Kevin Murphy; Peter Kinirons; Deirdre O'Rourke; Dongliang Ge; Chantal Depondt; Kristl G Claeys; Massimo Pandolfo; Curtis Gumbs; Nicole Walley; James McNamara; John C Mulley; Kristen N Linney; Leslie J Sheffield; Rodney A Radtke; Sarah K Tate; Stephanie L Chissoe; Rachel A Gibson; David Hosford; Alice Stanton; Tracey D Graves; Michael G Hanna; Kai Eriksson; Anne-Mari Kantanen; Reetta Kalviainen; Terence J O'Brien; Josemir W Sander; John S Duncan; Ingrid E Scheffer; Samuel F Berkovic; Nicholas W Wood; Colin P Doherty; Norman Delanty; Sanjay M Sisodiya; David B Goldstein
Journal:  Lancet Neurol       Date:  2007-11       Impact factor: 44.182

7.  Inhibitory effects of the antiepileptic drug ethosuximide on G protein-activated inwardly rectifying K+ channels.

Authors:  Toru Kobayashi; Hirokazu Hirai; Masae Iino; Ichiro Fuse; Kazuhiro Mitsumura; Kazuo Washiyama; Shinya Kasai; Kazutaka Ikeda
Journal:  Neuropharmacology       Date:  2008-10-17       Impact factor: 5.250

Review 8.  Genetics of the epilepsies.

Authors:  Eva Gutierrez-Delicado; José M Serratosa
Journal:  Curr Opin Neurol       Date:  2004-04       Impact factor: 5.710

9.  Genome-wide mapping of in vivo protein-DNA interactions.

Authors:  David S Johnson; Ali Mortazavi; Richard M Myers; Barbara Wold
Journal:  Science       Date:  2007-05-31       Impact factor: 47.728

10.  A homozygous mutation in human PRICKLE1 causes an autosomal-recessive progressive myoclonus epilepsy-ataxia syndrome.

Authors:  Alexander G Bassuk; Robyn H Wallace; Aimee Buhr; Andrew R Buller; Zaid Afawi; Masahito Shimojo; Shingo Miyata; Shan Chen; Pedro Gonzalez-Alegre; Hilary L Griesbach; Shu Wu; Marcus Nashelsky; Eszter K Vladar; Dragana Antic; Polly J Ferguson; Sebahattin Cirak; Thomas Voit; Matthew P Scott; Jeffrey D Axelrod; Christina Gurnett; Azhar S Daoud; Sara Kivity; Miriam Y Neufeld; Aziz Mazarib; Rachel Straussberg; Simri Walid; Amos D Korczyn; Diane C Slusarski; Samuel F Berkovic; Hatem I El-Shanti
Journal:  Am J Hum Genet       Date:  2008-10-30       Impact factor: 11.025

View more
  6 in total

1.  Transformation by E1A oncoprotein involves ubiquitin-mediated proteolysis of the neuronal and tumor repressor REST in the nucleus.

Authors:  Hancheng Guan; Robert P Ricciardi
Journal:  J Virol       Date:  2012-03-14       Impact factor: 5.103

Review 2.  Epileptogenesis after prolonged febrile seizures: mechanisms, biomarkers and therapeutic opportunities.

Authors:  Shawn McClelland; Céline M Dubé; Jaqueline Yang; Tallie Z Baram
Journal:  Neurosci Lett       Date:  2011-02-26       Impact factor: 3.046

3.  Differential activity by polymorphic variants of a remote enhancer that supports galanin expression in the hypothalamus and amygdala: implications for obesity, depression and alcoholism.

Authors:  Scott Davidson; Marissa Lear; Lynne Shanley; Benjamin Hing; Amanda Baizan-Edge; Annika Herwig; John P Quinn; Gerome Breen; Peter McGuffin; Andrew Starkey; Perry Barrett; Alasdair MacKenzie
Journal:  Neuropsychopharmacology       Date:  2011-06-29       Impact factor: 7.853

4.  The transcription factor NRSF contributes to epileptogenesis by selective repression of a subset of target genes.

Authors:  Shawn McClelland; Gary P Brennan; Celine Dubé; Seeta Rajpara; Shruti Iyer; Cristina Richichi; Christophe Bernard; Tallie Z Baram
Journal:  Elife       Date:  2014-08-12       Impact factor: 8.140

Review 5.  Transcription factors are potential therapeutic targets in epilepsy.

Authors:  Qihan Sun; Wenbo Xu; Jingjing Piao; Jingyun Su; Tongtong Ge; Ranji Cui; Wei Yang; Bingjin Li
Journal:  J Cell Mol Med       Date:  2022-09-06       Impact factor: 5.295

6.  NRSF and BDNF polymorphisms as biomarkers of cognitive dysfunction in adults with newly diagnosed epilepsy.

Authors:  Alix Warburton; Fabio Miyajima; Kanvel Shazadi; Joanne Crossley; Michael R Johnson; Anthony G Marson; Gus A Baker; John P Quinn; Graeme J Sills
Journal:  Epilepsy Behav       Date:  2015-12-17       Impact factor: 2.937

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.